Chemotherapy vs. Immunotherapy in combating nCOVID19: An update

A Choudhury, G Mukherjee, S Mukherjee - Human Immunology, 2021 - Elsevier
The nCOVID-19 pandemic initiated its course of contagion from the city of Wuhan and now it
has spread all over the globe. SARS-CoV-2 is the causative virus and the infection as well …

An overview of some potential immunotherapeutic options against COVID-19

M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - International …, 2021 - Elsevier
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

Why haven't we found an effective treatment for COVID-19?

AJ Spicer, S Jalkanen - Frontiers in Immunology, 2021 - frontiersin.org
The COVID-19 pandemic continues to grip the world, with significant ramifications not only
for public health but also for all major economies and industries. The scientific and medical …

New therapeutic approaches for SARS-CoV-2/COVID-19

AJ Rodriguez-Morales, AN Barbosa… - Frontiers in …, 2023 - frontiersin.org
After three years and a half since the pandemic due to the Severe Acute Respiratory
Syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus Disease 2019 (COVID-19) …

[HTML][HTML] Perspective adjunctive therapies for COVID-19: beyond antiviral therapy

P Ho, JQ Zheng, CC Wu, YC Hou, WC Liu… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic is the largest health crisis
ever faced worldwide. It has resulted in great health and economic costs because no …

Immunotherapy summary for cytokine storm in COVID-19

Y Li, W Zhao, J Liu, Z Chen, Q Lv… - Frontiers in Pharmacology, 2021 - frontiersin.org
COVID-19 pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has ravaged the world, resulting in an alarming number of infections and deaths …

Immunomodulation: a broad perspective for patients' survival of COVID-19 infection

CF Adeboboye, BO Oladejo… - European Journal of …, 2020 - journals.tmkarpinski.com
The pathogenesis of the SARS-CoV-2 virus is yet to be well understood. However, patients
with the virus show clinical manifestations which are very similar to those of SARS-CoV and …

Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …

AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …

[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

MS Mirtaleb, AH Mirtaleb, H Nosrati… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …